ArticleEndocrinology2009

Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.

Raul M Luque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.